OCRA’s support and education programs are available to help you navigate your diagnosis, treatment, and life after cancer. We are here to support you and your family, offering layers of support and many ways to connect.
OCRA is the world’s largest non-government funder of ovarian cancer research and has invested more than $110 million into desperately-needed breakthroughs.
OCRA is the voice for the ovarian cancer community, engaging with policymakers to keep this fight a priority. Learn more about our policy positions and discover how you can take action.
The ovarian cancer community needs you— your support, your voice, your passion and commitment. There are so many ways to lend a hand, to improve the lives of thousands of patients and their families, and get us one step closer to a cure.
In August, OCRA hosted a listening session with the U.S. Food and Drug Administration (FDA) to better understand the impact of Covid-19 on clinical trial participation.
Watch the full FDA listening session in the video below.
October 15, 2020
Advocacy, Community, OCRA News, Research
The Overview: October 2020
Focusing on the Next Line of Defense Against Ovarian Cancer | Meet a Scientist